Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab
E.S.G. Stroes, D.M. Colquhoun, D.R. Sullivan, F. Civeira, R.S. Rosenson, Gerald Watts, E. Bruckert, L. Cho, R.E. Dent, B. Knusel, A. Xue, R.A.H. Scott, S.M. Wasserman, M.B. Rocco
Dive into the research topics of 'Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab'. Together they form a unique fingerprint.